This trial compares two techniques to see which is better at preventing collapsed lung during a robotic surgery.
1 Primary · 0 Secondary · Reporting Duration: through study completion; an average of 1 year.
Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 5.0
2 Treatment Groups
1 of 2
1 of 2
60 Total Participants · 2 Treatment Groups
Primary Treatment: Group 1 · No Placebo Group · N/A
ProcedureExperimental Group · 1 Intervention: Ventilatory Strategy To Prevent Atelectasis · Intervention Types: Procedure
ProcedureExperimental Group · 1 Intervention: Lateral Decubitus Strategy (LADS) · Intervention Types: Procedure
Screening: ~3 weeks
Reporting: through study completion; an average of 1 year.
Who is running the clinical trial?
M.D. Anderson Cancer CenterLead Sponsor
2,827 Previous Clinical Trials
1,792,787 Total Patients Enrolled
Roberto Casal, MDPrincipal InvestigatorM.D. Anderson Cancer Center
2 Previous Clinical Trials
171 Total Patients Enrolled
Age 18+ · All Participants · 4 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is enrollment for this investigation still ongoing?
"Reportedly, according to the clinicaltrials.gov page, this trial is no longer recruiting patients. Initially posted on July 30th 2023 and last updated in January 26th 2023, there are 15 other trials that participants can contribute to instead." - Anonymous Online Contributor